Nkarta is a clinical-stage cell therapy company focused on engineered natural killer, or NK, cells for the treatment of cancer.
Nkarta Collaboration Achieves Cost-Effective Manufacturing in Tight Timelines Read More »
DiscGenics is a biopharmaceutical company that develops regenerative cell-based…
Avectas is an Ireland-based cell engineering technology company developing a unique intracellular delivery platform to enable ex vivo cell-based therapies.
Establishing a bank of 100 patient-derived iPSC lines and isogenic controls…
The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT) Read More »
An optimized 14-day manufacturing workflow developed in < 12 months...
Process Development for Scaled-Up hESC/hiPSC Manufacturing Read More »
Translation of a cell therapy protocol from bench-scale to bioreactor…
ACF media achieved comparable performance to serum containing…
Animal Component Free (ACF) Media Development for Cell Therapies Read More »
